| Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial | |
| Qin, Yan; Song, Yuqin; Shen, Zhixiang; Du, Xin; Ji, Wei; Hsu, Wanling; Zhu, Jun; Shi, Yuankai | |
| 2018 | |
| 卷号 | 38期号:1页码:31 |
| 关键词 | Obinutuzumab B-cell lymphoma Chronic lymphocytic leukemia Chinese patients |
| ISSN号 | 2523-3548 |
| DOI | 10.1186/s40880-018-0300-5 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6358107 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Qin, Yan,Song, Yuqin,Shen, Zhixiang,et al. Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial[J],2018,38(1):31. |
| APA | Qin, Yan.,Song, Yuqin.,Shen, Zhixiang.,Du, Xin.,Ji, Wei.,...&Shi, Yuankai.(2018).Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial.,38(1),31. |
| MLA | Qin, Yan,et al."Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial".38.1(2018):31. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论